🎉 M&A multiples are live!
Check it out!

LENSAR Valuation Multiples

Discover revenue and EBITDA valuation multiples for LENSAR and similar public comparables like Myomo, SmartVest, and Perspective Therapeutics.

LENSAR Overview

About LENSAR

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.


Founded

2004

HQ

United States of America
Employees

140

Website

lensar.com

Financials

LTM Revenue $57.7M

LTM EBITDA -$3.4M

EV

$141M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

LENSAR Financials

LENSAR has a last 12-month revenue of $57.7M and a last 12-month EBITDA of -$3.4M.

In the most recent fiscal year, LENSAR achieved revenue of $53.5M and an EBITDA of -$3.0M.

LENSAR expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See LENSAR valuation multiples based on analyst estimates

LENSAR P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $42.2M $53.5M XXX XXX XXX
Gross Profit $20.0M $21.1M XXX XXX XXX
Gross Margin 47% 39% XXX XXX XXX
EBITDA -$8.7M -$3.0M XXX XXX XXX
EBITDA Margin -21% -6% XXX XXX XXX
Net Profit -$19.9M -$14.4M XXX XXX XXX
Net Margin -47% -27% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

LENSAR Stock Performance

As of April 15, 2025, LENSAR's stock price is $14.

LENSAR has current market cap of $161M, and EV of $141M.

See LENSAR trading valuation data

LENSAR Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$141M $161M XXX XXX XXX XXX $-2.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

LENSAR Valuation Multiples

As of April 15, 2025, LENSAR has market cap of $161M and EV of $141M.

LENSAR's trades at 2.5x LTM EV/Revenue multiple, and -41.8x LTM EBITDA.

Analysts estimate LENSAR's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for LENSAR and 10K+ public comps

LENSAR Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $141M XXX XXX XXX
EV/Revenue 2.6x XXX XXX XXX
EV/EBITDA -47.1x XXX XXX XXX
P/E -5.1x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -58.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get LENSAR Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

LENSAR Valuation Multiples

LENSAR's NTM/LTM revenue growth is 28%

LENSAR's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, LENSAR's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate LENSAR's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for LENSAR and other 10K+ public comps

LENSAR Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 27% XXX XXX XXX XXX
EBITDA Margin -6% XXX XXX XXX XXX
EBITDA Growth -66% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 22% XXX XXX XXX XXX
Revenue per Employee $0.4M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 10% XXX XXX XXX XXX
Opex to Revenue 61% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

LENSAR Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

LENSAR M&A and Investment Activity

LENSAR acquired  XXX companies to date.

Last acquisition by LENSAR was  XXXXXXXX, XXXXX XXXXX XXXXXX . LENSAR acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by LENSAR

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About LENSAR

When was LENSAR founded? LENSAR was founded in 2004.
Where is LENSAR headquartered? LENSAR is headquartered in United States of America.
How many employees does LENSAR have? As of today, LENSAR has 140 employees.
Who is the CEO of LENSAR? LENSAR's CEO is Mr. Nicholas T. Curtis.
Is LENSAR publicy listed? Yes, LENSAR is a public company listed on NAS.
What is the stock symbol of LENSAR? LENSAR trades under LNSR ticker.
When did LENSAR go public? LENSAR went public in 2020.
Who are competitors of LENSAR? Similar companies to LENSAR include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of LENSAR? LENSAR's current market cap is $161M
What is the current revenue of LENSAR? LENSAR's last 12-month revenue is $57.7M.
What is the current EBITDA of LENSAR? LENSAR's last 12-month EBITDA is -$3.4M.
What is the current EV/Revenue multiple of LENSAR? Current revenue multiple of LENSAR is 2.5x.
What is the current EV/EBITDA multiple of LENSAR? Current EBITDA multiple of LENSAR is -41.8x.
What is the current revenue growth of LENSAR? LENSAR revenue growth between 2023 and 2024 was 27%.
Is LENSAR profitable? Yes, LENSAR is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.